CHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in ...

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...

The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent ...

CHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Bariatric surgery is associated with a significantly greater long-term weight loss than treatment with GLP-1 receptor ...

Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.

A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...

Shiru is inviting partners to harness its AI-powered ingredient discovery platform to explore ingredients that naturally ...

GLP-1 therapies primarily use single-use injectable pens, contributing to medical waste challenges. The pharmaceutical ...